Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H40O3 |
| Molecular Weight | 316.5191 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCOC[C@@H](O)CO
InChI
InChIKey=OOWQBDFWEXAXPB-IBGZPJMESA-N
InChI=1S/C19H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-22-18-19(21)17-20/h19-21H,2-18H2,1H3/t19-/m0/s1
| Molecular Formula | C19H40O3 |
| Molecular Weight | 316.5191 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| An update on the therapeutic role of alkylglycerols. | 2010-08-05 |
|
| Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis. | 2010-03-19 |
|
| [Synthesis and antitumor activity of selenophosphocholine analogues containing tegafur]. | 2006-12 |
|
| Two-dimensional facets in Langmuir monolayers of 1-O-hexadecyl-rac-glycerol at the air-water interface. | 2006-04-01 |
|
| 1-O-Alkylglycerol vesicles (Algosomes): their formation and characterization. | 2002-10-10 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:31:59 GMT 2025
by
admin
on
Mon Mar 31 20:31:59 GMT 2025
|
| Record UNII |
UJ10V6YY6H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C004348
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
10448487
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
m3330
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
208-026-6
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
DTXSID501018752
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
UJ10V6YY6H
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
76061
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
34115
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY | |||
|
506-03-6
Created by
admin on Mon Mar 31 20:31:59 GMT 2025 , Edited by admin on Mon Mar 31 20:31:59 GMT 2025
|
PRIMARY |